Theresa Ikegwuonu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Theresa Ikegwuonu has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Anita Schick
Department of Public Mental Health, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
4 shared publications - Inez Myin-Germeys
Center for Contextual Psychiatry, Department of Neurosciences, KU Leuven, Leuven, Belgium
4 shared publications - Julia C. C. Schulte-Strathaus
Department of Public Mental Health, Central Institute of Mental Health, Heidelberg University, Mannheim, Germany
4 shared publications - Lotte Uyttebroek
KU Leuven
4 shared publications - Maria Klara Wolters
School of Informatics, University of Edinburgh, Edinburgh, UK
4 shared publications - Michal Hajdúk
Department of Psychology, Faculty of Arts, Comenius University in Bratislava
4 shared publications
Latest Publications
- Open Access
- 11 March 2026
- Published by Center for Open Science in PsyArXiv
Self-tracking Habits and Technology Use among Mental Healthcare Service Users in Four European Countries – Examining the implementation potential of digital self-monitoring tools in mental healthcare
BACKGROUND: Digital self-monitoring tools, such as the Experience Sampling Methods (ESM), can be used to support mental health delivery and improve individuals’ self-management. However, like many digital health interventions, ESM tools struggle to achieve routine implementation into clinical practice and decision making. Existing habits are major predictors of the adoption of new technologies. Examining individuals’ technology and self-monitoring habits can therefore inform the implementation of digital self-monitoring tools in mental healthcare.OBJECTIVES: This study examines the adoption potential of digital self-monitoring tools among mental healthcare service users across four European countries, by (1) identifying and quantifying user type patterns in self-monitoring behavior and technology usage, and (2) examining whether user types differ in terms of demographic characteristics, attitudes towards technology, and psychiatric diagnosis. METHODS: A latent class analysis was performed on data from 435 mental healthcare service users participating in an anonymous online survey across Belgium, Germany, Scotland, and Slovakia. Multinomial logistic regression was used to examine how class membership was associated with different covariates. RESULTS: Findings showed that while only one-fourth of participants had experience with digital self-tracking, the majority of mental healthcare service users were interested in self-tracking. Based on self-tracking and technology use habits, four classes of users were identified; the ‘’digital trackers’’, the ‘’non-digital trackers’’, the ‘’interested non-trackers’’, and the ‘’non-interested non-trackers’’. Covariate analysis suggests that older and less educated individuals might require more support and guidance to utilize digital self-monitoring tools. Furthermore, lower preferences for task-switching and lower positive attitudes toward technology might explain why some individuals do not use digital self-monitoring tools. CONCLUSION: To enable better uptake, implementation approaches should be tailored to meet the needs and preferences of different types of users. Future research should aim to develop a more in-depth understanding of drivers and barriers experienced by members belonging to the different classes.
- 11 March 2026
- Published by Center for Open Science in PsyArXiv
Open AccessSelf-tracking Habits and Technology Use among Mental Healthcare Service Users in Four European Countries – Examining the implementation potential of digital self-monitoring tools in mental healthcare
BACKGROUND: Digital self-monitoring tools, such as the Experience Sampling Methods (ESM), can be used to support mental health delivery and improve individuals’ self-management. However, like many digital health interventions, ESM tools struggle to achieve routine implementation into clinical practice and decision making. Existing habits are major predictors of the adoption of new technologies. Examining individuals’ technology and self-monitoring habits can therefore inform the implementation of digital self-monitoring tools in mental healthcare.OBJECTIVES: This study examines the adoption potential of digital self-monitoring tools among mental healthcare service users across four European countries, by (1) identifying and quantifying user type patterns in self-monitoring behavior and technology usage, and (2) examining whether user types differ in terms of demographic characteristics, attitudes towards technology, and psychiatric diagnosis. METHODS: A latent class analysis was performed on data from 435 mental healthcare service users participating in an anonymous online survey across Belgium, Germany, Scotland, and Slovakia. Multinomial logistic regression was used to examine how class membership was associated with different covariates. RESULTS: Findings showed that while only one-fourth of participants had experience with digital self-tracking, the majority of mental healthcare service users were interested in self-tracking. Based on self-tracking and technology use habits, four classes of users were identified; the ‘’digital trackers’’, the ‘’non-digital trackers’’, the ‘’interested non-trackers’’, and the ‘’non-interested non-trackers’’. Covariate analysis suggests that older and less educated individuals might require more support and guidance to utilize digital self-monitoring tools. Furthermore, lower preferences for task-switching and lower positive attitudes toward technology might explain why some individuals do not use digital self-monitoring tools. CONCLUSION: To enable better uptake, implementation approaches should be tailored to meet the needs and preferences of different types of users. Future research should aim to develop a more in-depth understanding of drivers and barriers experienced by members belonging to the different classes.
- Open Access
- 15 January 2026
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 10, e79510
Preferences for an Experience Sampling Method–Based Tool as an Adjunct to Usual Treatment in Patients With Problem Substance Use: Qualitative Study
Background: Mobile health tools that use the Experience Sampling Method (ESM) appear to be a promising tool to streamline and improve the treatment of substance use disorders. However, patient involvement in the development of these tools is uncommon, and research on the preferences of people being treated for substance use disorders has been scarce. In the scope of the European Union IMMERSE (Implementing Mobile Mental health Recording Strategy for Europe) consortium, an ESM-based tool for Digital Mobile Mental Health (DMMH) was first codeveloped and later tested in 4 European countries. Objective: This study aimed to achieve an understanding of preferences for features of DMMH among mental health service users with problem substance use. Methods: In 4 European countries, service users were recruited for a semistructured qualitative interview, which started with the presentation of a prototype of the DMMH. Data analysis was performed through directed qualitative content analysis. Results: The analytical sample consisted of 12 (5 female, 6 male, and 1 nonbinary person) participants with problem substance use aged 18-50 years. There were 4 participants from Slovakia, 3 from Belgium, 4 from Germany, and 1 from Scotland. Patient preferences were classified into 7 categories: notifications, questions, user interface, functionality changes, visualizations, sharing data with clinicians, and sharing data with others. The proposed intensive notification schedule was deemed acceptable by service users as long as the questionnaire is short. Participants expressed a preference for open-text response options, Ecological Momentary Interventions, and options for individual customization of several elements of the tool. Data visualization was considered an important aid for communication with clinicians, with whom all participants wanted to share data obtained with DMMH. The possibility of sharing data with other people depended on the quality of the relationship with them. Conclusions: In the development of ESM-based mobile health tools for people with problem substance use, their preferences for content, functionality, and appearance of the tools should be considered so they match patients’ treatment needs.
- 15 January 2026
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 10, e79510
Open AccessPreferences for an Experience Sampling Method–Based Tool as an Adjunct to Usual Treatment in Patients With Problem Substance Use: Qualitative Study
Background: Mobile health tools that use the Experience Sampling Method (ESM) appear to be a promising tool to streamline and improve the treatment of substance use disorders. However, patient involvement in the development of these tools is uncommon, and research on the preferences of people being treated for substance use disorders has been scarce. In the scope of the European Union IMMERSE (Implementing Mobile Mental health Recording Strategy for Europe) consortium, an ESM-based tool for Digital Mobile Mental Health (DMMH) was first codeveloped and later tested in 4 European countries. Objective: This study aimed to achieve an understanding of preferences for features of DMMH among mental health service users with problem substance use. Methods: In 4 European countries, service users were recruited for a semistructured qualitative interview, which started with the presentation of a prototype of the DMMH. Data analysis was performed through directed qualitative content analysis. Results: The analytical sample consisted of 12 (5 female, 6 male, and 1 nonbinary person) participants with problem substance use aged 18-50 years. There were 4 participants from Slovakia, 3 from Belgium, 4 from Germany, and 1 from Scotland. Patient preferences were classified into 7 categories: notifications, questions, user interface, functionality changes, visualizations, sharing data with clinicians, and sharing data with others. The proposed intensive notification schedule was deemed acceptable by service users as long as the questionnaire is short. Participants expressed a preference for open-text response options, Ecological Momentary Interventions, and options for individual customization of several elements of the tool. Data visualization was considered an important aid for communication with clinicians, with whom all participants wanted to share data obtained with DMMH. The possibility of sharing data with other people depended on the quality of the relationship with them. Conclusions: In the development of ESM-based mobile health tools for people with problem substance use, their preferences for content, functionality, and appearance of the tools should be considered so they match patients’ treatment needs.
- Open Access
- 22 December 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27, e72893
Visualization of Experience Sampling Method Data in Mental Health: Qualitative Study of the Physicians’ Perspective in Germany
Background: Although the integration of self-monitored patient data into mental health care offers potential for advancing personalized approaches, its application in clinical practice remains largely underexplored. Capturing individuals’ mental health outside the therapy room using experience sampling methodology (ESM) may bridge this gap by supporting shared decision-making and personalized interventions. Objective: This qualitative study investigated the perspectives of German mental health professionals regarding prototypes of ESM data visualizations designed for integration into a digital mental health tool. Methods: Semistructured interviews were conducted with clinicians on their perceptions of such visualizations in routine care. Results: Using reflexive thematic analysis, 3 key findings emerged (1) ESM and ESM data visualizations were seen as valuable tools for enhancing patient motivation and engagement over the course of treatment; (2) simplicity and clarity of visual formats, particularly line graphs, were preferred for usability; and (3) practical concerns, such as workflow integration challenges centered on time constraints (psychotherapy session duration 50 min) and need for patient psychoeducation materials, influenced perceived utility. Challenges, including the risk of cognitive overload from dense data representations (eg, ESM mood-in-context visualizations), were raised. Conclusions: These findings underline the importance of designing digital tools that align with clinical needs while addressing potential barriers to implementation by exploring the opportunities and challenges associated with ESM visualizations.
- 22 December 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27, e72893
Open AccessVisualization of Experience Sampling Method Data in Mental Health: Qualitative Study of the Physicians’ Perspective in Germany
Background: Although the integration of self-monitored patient data into mental health care offers potential for advancing personalized approaches, its application in clinical practice remains largely underexplored. Capturing individuals’ mental health outside the therapy room using experience sampling methodology (ESM) may bridge this gap by supporting shared decision-making and personalized interventions. Objective: This qualitative study investigated the perspectives of German mental health professionals regarding prototypes of ESM data visualizations designed for integration into a digital mental health tool. Methods: Semistructured interviews were conducted with clinicians on their perceptions of such visualizations in routine care. Results: Using reflexive thematic analysis, 3 key findings emerged (1) ESM and ESM data visualizations were seen as valuable tools for enhancing patient motivation and engagement over the course of treatment; (2) simplicity and clarity of visual formats, particularly line graphs, were preferred for usability; and (3) practical concerns, such as workflow integration challenges centered on time constraints (psychotherapy session duration 50 min) and need for patient psychoeducation materials, influenced perceived utility. Challenges, including the risk of cognitive overload from dense data representations (eg, ESM mood-in-context visualizations), were raised. Conclusions: These findings underline the importance of designing digital tools that align with clinical needs while addressing potential barriers to implementation by exploring the opportunities and challenges associated with ESM visualizations.
- Open Access
- 23 June 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Preferences for an Experience Sampling Method–Based Tool as an Adjunct to Usual Treatment in Patients With Problem Substance Use: Qualitative Study (Preprint)
BACKGROUND Mobile health tools that use the Experience Sampling Method (ESM) appear to be a promising tool to streamline and improve the treatment of substance use disorders. However, patient involvement in the development of these tools is uncommon, and research on the preferences of people being treated for substance use disorders has been scarce. In the scope of the European Union IMMERSE (Implementing Mobile Mental health Recording Strategy for Europe) consortium, an ESM-based tool for Digital Mobile Mental Health (DMMH) was first codeveloped and later tested in 4 European countries. OBJECTIVE This study aimed to achieve an understanding of preferences for features of DMMH among mental health service users with problem substance use. METHODS In 4 European countries, service users were recruited for a semistructured qualitative interview, which started with the presentation of a prototype of the DMMH. Data analysis was performed through directed qualitative content analysis. RESULTS The analytical sample consisted of 12 (5 female, 6 male, and 1 nonbinary person) participants with problem substance use aged 18-50 years. There were 4 participants from Slovakia, 3 from Belgium, 4 from Germany, and 1 from Scotland. Patient preferences were classified into 7 categories: notifications, questions, user interface, functionality changes, visualizations, sharing data with clinicians, and sharing data with others. The proposed intensive notification schedule was deemed acceptable by service users as long as the questionnaire is short. Participants expressed a preference for open-text response options, Ecological Momentary Interventions, and options for individual customization of several elements of the tool. Data visualization was considered an important aid for communication with clinicians, with whom all participants wanted to share data obtained with DMMH. The possibility of sharing data with other people depended on the quality of the relationship with them. CONCLUSIONS In the development of ESM-based mobile health tools for people with problem substance use, their preferences for content, functionality, and appearance of the tools should be considered so they match patients’ treatment needs.
- 23 June 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessPreferences for an Experience Sampling Method–Based Tool as an Adjunct to Usual Treatment in Patients With Problem Substance Use: Qualitative Study (Preprint)
BACKGROUND Mobile health tools that use the Experience Sampling Method (ESM) appear to be a promising tool to streamline and improve the treatment of substance use disorders. However, patient involvement in the development of these tools is uncommon, and research on the preferences of people being treated for substance use disorders has been scarce. In the scope of the European Union IMMERSE (Implementing Mobile Mental health Recording Strategy for Europe) consortium, an ESM-based tool for Digital Mobile Mental Health (DMMH) was first codeveloped and later tested in 4 European countries. OBJECTIVE This study aimed to achieve an understanding of preferences for features of DMMH among mental health service users with problem substance use. METHODS In 4 European countries, service users were recruited for a semistructured qualitative interview, which started with the presentation of a prototype of the DMMH. Data analysis was performed through directed qualitative content analysis. RESULTS The analytical sample consisted of 12 (5 female, 6 male, and 1 nonbinary person) participants with problem substance use aged 18-50 years. There were 4 participants from Slovakia, 3 from Belgium, 4 from Germany, and 1 from Scotland. Patient preferences were classified into 7 categories: notifications, questions, user interface, functionality changes, visualizations, sharing data with clinicians, and sharing data with others. The proposed intensive notification schedule was deemed acceptable by service users as long as the questionnaire is short. Participants expressed a preference for open-text response options, Ecological Momentary Interventions, and options for individual customization of several elements of the tool. Data visualization was considered an important aid for communication with clinicians, with whom all participants wanted to share data obtained with DMMH. The possibility of sharing data with other people depended on the quality of the relationship with them. CONCLUSIONS In the development of ESM-based mobile health tools for people with problem substance use, their preferences for content, functionality, and appearance of the tools should be considered so they match patients’ treatment needs.
- 26 March 2021
- Published by BMJ in Tobacco Control
- Vol. 31 (4) , 511-519
Understanding commercial actors’ engagement in policy debates on proposed e-cigarette regulation in Scotland
Introduction There is growing concern about transnational tobacco corporations’ (TTCs) and other commercial actors’ involvement in e-cigarette policy development. Previous analyses suggest that TTCs used e-cigarette debates to demonstrate alignment with public health and re-gain policy influence. Less is known about the engagement of other types of commercial actors in e-cigarette policy debates. Methods This paper is the first to empirically analyse commercial actors’ engagement in an e-cigarette policy consultation process and to examine their views on proposed regulation. It applies mixed methods, drawing on policy consultation submissions (n=32), semi-structured interviews (n=9) and a social network analysis of website links among 32 commercial actors. Results The results show that commercial actors’ positions on e-cigarette regulation aligned with business interests. TTCs, independent e-cigarette manufacturers and other non-licensed commercial actors were opposed to most aspects of potential e-cigarette regulation (except for age of sale restrictions), whereas licensed commercial actors, including pharmaceutical companies, supported more stringent regulation. While collaboration was viewed as strategically important to gain policy influence, distinct commercial interests and concerns about TTC credibility led to strategic distancing and to collaboration being largely confined to sector boundaries. In addition to reiterating arguments employed by TTCs in previous regulatory debates, commercial actors focused on highlighting the technical complexity and harm reduction potential of e-cigarettes. Conclusion Awareness of the various commercial interests and strategic positioning of commercial actors in e-cigarette policy should inform public health advocacy and policy development, including managing conflicts of interest in the context of Framework Convention on Tobacco Control Article 5.3.
- 26 March 2021
- Published by BMJ in Tobacco Control
- Vol. 31 (4) , 511-519
Understanding commercial actors’ engagement in policy debates on proposed e-cigarette regulation in Scotland
Introduction There is growing concern about transnational tobacco corporations’ (TTCs) and other commercial actors’ involvement in e-cigarette policy development. Previous analyses suggest that TTCs used e-cigarette debates to demonstrate alignment with public health and re-gain policy influence. Less is known about the engagement of other types of commercial actors in e-cigarette policy debates. Methods This paper is the first to empirically analyse commercial actors’ engagement in an e-cigarette policy consultation process and to examine their views on proposed regulation. It applies mixed methods, drawing on policy consultation submissions (n=32), semi-structured interviews (n=9) and a social network analysis of website links among 32 commercial actors. Results The results show that commercial actors’ positions on e-cigarette regulation aligned with business interests. TTCs, independent e-cigarette manufacturers and other non-licensed commercial actors were opposed to most aspects of potential e-cigarette regulation (except for age of sale restrictions), whereas licensed commercial actors, including pharmaceutical companies, supported more stringent regulation. While collaboration was viewed as strategically important to gain policy influence, distinct commercial interests and concerns about TTC credibility led to strategic distancing and to collaboration being largely confined to sector boundaries. In addition to reiterating arguments employed by TTCs in previous regulatory debates, commercial actors focused on highlighting the technical complexity and harm reduction potential of e-cigarettes. Conclusion Awareness of the various commercial interests and strategic positioning of commercial actors in e-cigarette policy should inform public health advocacy and policy development, including managing conflicts of interest in the context of Framework Convention on Tobacco Control Article 5.3.
- Open Access
- 26 August 2019
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 16 (17) , 3103
E-Cigarettes: A Disruptive Technology? An Analysis of Health Actors’ Positions on E-Cigarette Regulation in Scotland
Concerns have been raised that the divisions emerging within public health in response to electronic cigarettes are weakening tobacco control. This paper employed thematic and network analysis to assess 90 policy consultation submissions and 18 interviews with political actors to examine the extent of, and basis for, divisions between health-focused actors with regard to the harms and benefits of e-cigarettes and appropriate approaches to regulation in Scotland. The results demonstrated considerable engagement in e-cigarette policy development by health-focused actors and a widely held perception of strong disagreement. They show that actors agreed on substantive policy issues, such as age-of-sale restrictions and, in part, the regulation of advertising. Points of contestation were related to the harms and benefits of e-cigarettes and the regulation of vaping in public places. The topicality, limitations of the evidence base and underlying values may help explain the heightened sense of division. While suggesting that some opportunities for joint advocacy might have been missed, this analysis shows that debates on e-cigarette regulation cast a light upon differences in thinking about appropriate approaches to health policy development within the public health community. Constructive debates on these divisive issues among health-focused actors will be a crucial step toward advancing public health.
- 26 August 2019
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 16 (17) , 3103
Open AccessE-Cigarettes: A Disruptive Technology? An Analysis of Health Actors’ Positions on E-Cigarette Regulation in Scotland
Concerns have been raised that the divisions emerging within public health in response to electronic cigarettes are weakening tobacco control. This paper employed thematic and network analysis to assess 90 policy consultation submissions and 18 interviews with political actors to examine the extent of, and basis for, divisions between health-focused actors with regard to the harms and benefits of e-cigarettes and appropriate approaches to regulation in Scotland. The results demonstrated considerable engagement in e-cigarette policy development by health-focused actors and a widely held perception of strong disagreement. They show that actors agreed on substantive policy issues, such as age-of-sale restrictions and, in part, the regulation of advertising. Points of contestation were related to the harms and benefits of e-cigarettes and the regulation of vaping in public places. The topicality, limitations of the evidence base and underlying values may help explain the heightened sense of division. While suggesting that some opportunities for joint advocacy might have been missed, this analysis shows that debates on e-cigarette regulation cast a light upon differences in thinking about appropriate approaches to health policy development within the public health community. Constructive debates on these divisive issues among health-focused actors will be a crucial step toward advancing public health.
- Open Access
- 15 March 2018
- Published by Wiley in Health Science Reports
- Vol. 1 (4) , 30
Horizon scanning implanted biosensors in personalising breast cancer management: First pilot study of breast cancer patients views
Aims: This study aimed to explore breast cancer patients' understanding and acceptability of implanted biosensors (BS) within the primary tumour to personalise adjuvant radiotherapy, and to determine optimal design and number of BS, and evaluate potential clinical benefits as well as concerns about tolerance, toxicity, dwell time, and confidentiality of data.Patients and methods: A total of 32 patients treated by surgery (29 breast conserving, 3 mastectomy), postoperative radiotherapy and systemic therapy for early breast cancer, were recruited from a posttreatment radiotherapy clinic at a cancer centre. Patients participated in semistructured interviews. Interview transcripts were analysed using qualitative methods.Results: Participants were aged 39 to 87 years, with a median age of 62 years. Most (N = 23[72%]) were unfamiliar with biosensors. The majority (N = 29[90.6%]) were supportive of the technology's potential use in future breast cancer treatment and were willing to accept biosensors (N = 28[88%]) if they were endorsed by their breast cancer consultant. Only 3 patients expressed concerns, predominantly about uncertainties on their role in the diagnostic and treatment pathway. Patients were flexible about the size and shape of BS, but had a preference for small size (N = 28 [87.5%]). Most (N = 22[69%]) would accept implantation of more than 5 BS and were flexible (N = 22[69%]) about indefinite dwell time. Patients had a strong preference for wireless powering of the BS (N = 28[87.5%]). Few had concerns about loss of confidentiality of data collected. All patients considered biosensors to be potentially of important clinical benefit.Conclusions: While knowledge of biosensors was limited, patients were generally supportive of biosensors implanted within the primary tumour to collect data that might personalise and improve breast cancer radiotherapy in future.
- 15 March 2018
- Published by Wiley in Health Science Reports
- Vol. 1 (4) , 30
Open AccessHorizon scanning implanted biosensors in personalising breast cancer management: First pilot study of breast cancer patients views
Aims: This study aimed to explore breast cancer patients' understanding and acceptability of implanted biosensors (BS) within the primary tumour to personalise adjuvant radiotherapy, and to determine optimal design and number of BS, and evaluate potential clinical benefits as well as concerns about tolerance, toxicity, dwell time, and confidentiality of data.Patients and methods: A total of 32 patients treated by surgery (29 breast conserving, 3 mastectomy), postoperative radiotherapy and systemic therapy for early breast cancer, were recruited from a posttreatment radiotherapy clinic at a cancer centre. Patients participated in semistructured interviews. Interview transcripts were analysed using qualitative methods.Results: Participants were aged 39 to 87 years, with a median age of 62 years. Most (N = 23[72%]) were unfamiliar with biosensors. The majority (N = 29[90.6%]) were supportive of the technology's potential use in future breast cancer treatment and were willing to accept biosensors (N = 28[88%]) if they were endorsed by their breast cancer consultant. Only 3 patients expressed concerns, predominantly about uncertainties on their role in the diagnostic and treatment pathway. Patients were flexible about the size and shape of BS, but had a preference for small size (N = 28 [87.5%]). Most (N = 22[69%]) would accept implantation of more than 5 BS and were flexible (N = 22[69%]) about indefinite dwell time. Patients had a strong preference for wireless powering of the BS (N = 28[87.5%]). Few had concerns about loss of confidentiality of data collected. All patients considered biosensors to be potentially of important clinical benefit.Conclusions: While knowledge of biosensors was limited, patients were generally supportive of biosensors implanted within the primary tumour to collect data that might personalise and improve breast cancer radiotherapy in future.
- Open Access
- 20 October 2017
- Published by Oxford University Press (OUP) in European Journal of Public Health
- Vol. 27 (suppl_3)
Organisational actors who engage in Scottish e-cigarette policy debates: A mixed methods approach
Electronic cigarettes have become subject to highly contested public and political debates, including the role of commercial actors in development and implementation of e-cigarette policy. There are concerns that e-cigarette debates provide opportunities for commercial actors to demonstrate alignment with public health interests, build reputation, and gain influence over policy processes. While previous research on commercial sector engagement in policymaking has enhanced understanding of its impact on public health, a striking research gap exists regarding commercial actors’ engagement in e-cigarette debates.
- 20 October 2017
- Published by Oxford University Press (OUP) in European Journal of Public Health
- Vol. 27 (suppl_3)
Open AccessOrganisational actors who engage in Scottish e-cigarette policy debates: A mixed methods approach
Electronic cigarettes have become subject to highly contested public and political debates, including the role of commercial actors in development and implementation of e-cigarette policy. There are concerns that e-cigarette debates provide opportunities for commercial actors to demonstrate alignment with public health interests, build reputation, and gain influence over policy processes. While previous research on commercial sector engagement in policymaking has enhanced understanding of its impact on public health, a striking research gap exists regarding commercial actors’ engagement in e-cigarette debates.